David Roman Analyst PerformanceManaging Director | Global Investment Research at The Goldman Sachs GroupDavid Roman is a stock analyst at The Goldman Sachs Group focused in the medical sector, covering 27 publicly traded companies. Over the past year, David Roman has issued 78 stock ratings, including buy, hold, and sell recommendations. While full access to David Roman's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights David Roman's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings89 Last 9 YearsBuy Recommendations48.78% 40 Buy RatingsCompanies Covered27 Unique Companies Ratings Distribution82RatingsDistribution of strong buy, buy, hold, and sell ratings by David Roman.RatingPercentageCount Strong Buy0.0%0 ratings Buy48.8%40 ratings Hold40.2%33 ratings Sell11.0%9 ratingsOut of 82 total stock ratings issued by David Roman at The Goldman Sachs Group, the majority (48.8%) have been Buy recommendations, followed by 40.2% Hold and 11.0% Sell.Best & Worst CallsBest Call000.0%BAXJul 2016Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%BAXFeb 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ51.9% of companies on NASDAQ14 companiesNYSE48.1% of companies on NYSE13 companiesDavid Roman, an analyst at The Goldman Sachs Group, currently covers 27 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical23 companies85.2%Manufacturing2 companies7.4%Miscellaneous1 company3.7%Services1 company3.7%David Roman of The Goldman Sachs Group specializes in stock coverage within the Medical sector, with additional focus on Manufacturing and companies.Coverage IndustriesIndustryPercentageMED PRODUCTS9 companies33.3%MED INSTRUMENTS6 companies22.2%MEDICAL SERVICES4 companies14.8%SURGICAL, MEDICAL, AND DENTAL INSTRUMENTS AND SUPPLIES3 companies11.1%MED/DENTAL - SUPP2 companies7.4%Miscellaneous1 company3.7%SERVICES – COMPUTER PROGRAMMING AND DATA PROCESSING1 company3.7%MEDICAL INFO SYS1 company3.7% David Roman's Ratings History at The Goldman Sachs Group Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsMDTMedtronic6/4/2026Lower Price Target$82.55$83.00Neutral$0.0000.00% ROIMOBIMobia Medical6/2/2026Initiated Coverage$13.50$31.00Buy$0.0000.00% ROIMOBIMobia Medical6/2/2026Initiated Coverage$13.73$31.00Buy$0.0000.00% ROIBSXBoston Scientific5/28/2026Set Price Target$49.03$71.00$0.0000.00% ROIISRGIntuitive Surgical5/27/2026Set Price Target$427.16$558.00$0.0000.00% ROITNDMTandem Diabetes Care5/27/2026Set Price Target$14.42$21.00$0.0000.00% ROIPODDInsulet5/27/2026Reiterated Rating$153.80$205.00Buy$0.0000.00% ROIBBNXBeta Bionics5/27/2026Lower Price Target$11.72$17.00Buy$0.0000.00% ROIABTAbbott Laboratories5/27/2026Lower Price Target$86.35$113.00Buy$0.0000.00% ROIBDXBecton, Dickinson and Company5/27/2026Lower Price Target$146.28$150.00Neutral$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. DOCSDoximity5/14/2026Lower Price Target$23.52$24.00Neutral$0.0000.00% ROIOMDAOmada Health5/8/2026Reiterated Rating$15.34Buy$0.0000.00% ROIPODDInsulet5/7/2026Set Price Target$160.40$237.00$0.0000.00% ROISYKStryker5/1/2026Reiterated Rating$295.43$361.00Neutral$0.0000.00% ROIGEHCGE HealthCare Technologies4/30/2026Downgrade$59.49$65.00Neutral$0.0000.00% ROIBSXBoston Scientific4/22/2026Lower Price Target$64.95$84.00Buy$0.0000.00% ROIISRGIntuitive Surgical4/22/2026Boost Price Target$481.31$621.00Buy$0.0000.00% ROIBDXBecton, Dickinson and Company4/10/2026Initiated Coverage$154.05$167.00Neutral$0.0000.00% ROIBDXBecton, Dickinson and Company4/9/2026Upgrade$154.07Hold$0.0000.00% ROITNDMTandem Diabetes Care4/9/2026Lower Price Target$19.81$25.00Neutral$0.0000.00% ROISYKStryker4/9/2026Lower Price Target$337.58$357.00Neutral$0.0000.00% ROIOMDAOmada Health4/9/2026Lower Price Target$11.82$23.00Buy$0.0000.00% ROIKMTSKestra Medical Technologies4/9/2026Lower Price Target$19.40$17.00Neutral$0.0000.00% ROIIRTCiRhythm Technologies4/9/2026Lower Price Target$119.00$147.00Neutral$0.0000.00% ROIGEHCGE HealthCare Technologies4/9/2026Lower Price Target$73.09$81.00Buy$0.0000.00% ROIDOCSDoximity4/9/2026Lower Price Target$21.11$28.00Neutral$0.0000.00% ROICARLCarlsmed4/9/2026Lower Price Target$9.82$17.00Buy$0.0000.00% ROIBBNXBeta Bionics4/9/2026Lower Price Target$10.02$20.00Buy$0.0000.00% ROIPODDInsulet4/8/2026Lower Price Target$202.46$277.00Buy$0.0000.00% ROIABTAbbott Laboratories4/8/2026Lower Price Target$101.77$121.00Buy$0.0000.00% ROIISRGIntuitive Surgical4/8/2026Lower Price Target$467.00$609.00Buy$0.0000.00% ROIBSXBoston Scientific3/27/2026Lower Price Target$69.22$93.00Buy$0.0000.00% ROITNDMTandem Diabetes Care2/23/2026Reiterated Rating$24.57$28.00Neutral$0.0000.00% ROIPODDInsulet2/19/2026Lower Price Target$258.07$326.00Buy$0.0000.00% ROIBAXBaxter International2/13/2026Lower Price Target$19.80$17.00Neutral$0.0000.00% ROIEWEdwards Lifesciences2/11/2026Reiterated Rating$77.00$95.00Buy$0.0000.00% ROIDOCSDoximity2/6/2026Lower Price Target$25.39$34.00Neutral$0.0000.00% ROIBSXBoston Scientific2/5/2026Set Price Target$74.95$99.00$0.0000.00% ROIOMDAOmada Health1/16/2026Reiterated Rating$15.65$26.00Buy$0.0000.00% ROIKMTSKestra Medical Technologies1/16/2026Set Price Target$22.25$24.00$0.0000.00% ROII was right about SpaceX (Ad)Jeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,000%. Now he says SpaceX is shaping up to be the biggest IPO of the decade - and three key milestones just confirmed it. In the past 21 days: SpaceX crossed 10,000 active satellites, Elon filed confidential IPO paperwork with the SEC, and another rocket launched 25 more satellites. Two-thirds of every satellite in orbit now belongs to one company. The public filing could drop any day.See how to claim your stake in SpaceX before the public canBBNXBeta Bionics1/15/2026Reiterated Rating$16.99$25.00Buy$0.0000.00% ROIMDLNMedline1/12/2026Initiated Coverage$40.52$49.00Buy$0.0000.00% ROIMDLNMedline1/12/2026Initiated Coverage$42.72$49.00Buy$0.0000.00% ROITNDMTandem Diabetes Care1/9/2026Reiterated Rating$22.50$25.00Neutral$0.0000.00% ROISIShoulder Innovations1/9/2026Reiterated Rating$15.04Buy$0.0000.00% ROILIVNLivaNova1/9/2026Reiterated Rating$64.95$66.00Neutral$0.0000.00% ROIKMTSKestra Medical Technologies1/9/2026Reiterated Rating$26.65$27.00Neutral$0.0000.00% ROIGKOSGlaukos1/9/2026Reiterated Rating$114.28$138.00Buy$0.0000.00% ROIBLCOBausch + Lomb1/9/2026Reiterated Rating$17.32$19.00Neutral$0.0000.00% ROIPODDInsulet1/9/2026Reiterated Rating$292.89$365.00Buy$0.0000.00% ROIEWEdwards Lifesciences1/9/2026Reiterated Rating$84.55$108.00Buy$0.0000.00% ROICOOCooper Companies1/9/2026Reiterated Rating$83.13$73.00Sell$0.0000.00% ROIBSXBoston Scientific1/9/2026Reiterated Rating$98.43$112.00Buy$0.0000.00% ROIZBHZimmer Biomet1/9/2026Downgrade$94.07$93.00Sell$0.0000.00% ROIHQYHealthEquity1/9/2026Downgrade$98.51$89.00Sell$0.0000.00% ROIDOCSDoximity1/9/2026Upgrade$43.71$49.00Buy$0.0000.00% ROIBAXBaxter International1/9/2026Boost Price Target$20.39$23.00Neutral$0.0000.00% ROIKMTSKestra Medical Technologies12/13/2025Boost Price Target$26.17$25.00Neutral$0.0000.00% ROICOOCooper Companies12/8/2025Reiterated Rating$81.40$71.00Sell$0.0000.00% ROIMDTMedtronic11/19/2025Set Price Target$100.83$111.00Neutral$0.0000.00% ROIMDTMedtronic11/19/2025Upgrade$100.12$111.00Neutral$0.0000.00% ROIEWEdwards Lifesciences10/31/2025Set Price Target$82.58$104.00Buy$0.0000.00% ROIBAXBaxter International10/31/2025Lower Price Target$18.73$22.00Neutral$0.0000.00% ROIIRTCiRhythm Technologies10/31/2025Boost Price Target$187.40$202.00Neutral$0.0000.00% ROIBBNXBeta Bionics10/29/2025Boost Price Target$24.28$33.00Buy$0.0000.00% ROICOOCooper Companies10/1/2025Set Price Target$68.53$64.00Sell$0.0000.00% ROIBLCOBausch + Lomb10/1/2025Initiated Coverage$15.08$16.00Neutral$0.0000.00% ROIGKOSGlaukos10/1/2025Initiated Coverage$81.67$103.00Buy$0.0000.00% ROIDOCSDoximity10/1/2025Set Price Target$73.22$64.00Sell$0.0000.00% ROIBBNXBeta Bionics10/1/2025Set Price Target$19.87$26.00Buy$0.0000.00% ROIIRTCiRhythm Technologies10/1/2025Boost Price Target$166.09$180.00Neutral$0.0000.00% ROIBBNXBeta Bionics10/1/2025Upgrade$20.21$26.00Buy$0.0000.00% ROIDOCSDoximity10/1/2025Reiterated Rating$70.67$64.00Sell$0.0000.00% ROIBLCOBausch + Lomb10/1/2025Initiated Coverage$14.76$16.00Neutral$0.0000.00% ROICOOCooper Companies10/1/2025Initiated Coverage$69.12$64.00Sell$0.0000.00% ROIGKOSGlaukos10/1/2025Initiated Coverage$84.56$103.00Buy$0.0000.00% ROISIShoulder Innovations8/25/2025Initiated Coverage$12.63$20.00Buy$0.0000.00% ROIOMDAOmada Health7/1/2025Initiated Coverage$18.30$29.00Buy$0.0000.00% ROIHQYHealthEquity6/4/2025Boost Price Target$113.10$104.00Neutral$00.0000.00% ROIBBNXBeta Bionics5/30/2025Initiated Coverage$15.36$16.00Neutral$00.0000.00% ROIZBHZimmer Biomet5/6/2025Lower Price Target$90.83$104.00Neutral$00.0000.00% ROIKMTSKestra Medical Technologies3/31/2025Initiated Coverage$23.43$24.00Neutral$00.0000.00% ROIGEHCGE HealthCare Technologies3/11/2025Upgrade$85.36$100.00Buy$00.0000.00% ROIABTAbbott Laboratories3/4/2025Boost Price Target$140.38$154.00Buy$000.0000.00% ROISOLVSolventum3/3/2025Boost Price Target$78.68$71.00Sell$00.0000.00% ROIBAXBaxter International2/26/2025Initiated Coverage$36.00$42.00Buy$00.0000.00% ROISYKStryker1/30/2025Boost Price Target$393.95$427.00Neutral$000.0000.00% ROIISRGIntuitive Surgical10/18/2024Set Price Target$521.89$604.00$000.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysWells Fargo & CompanyMorgan StanleyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerStifel NicolausRaymond James Financial Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
